{
    "Trade/Device Name(s)": [
        "Alinity c ICT Sample Diluent"
    ],
    "Submitter Information": "Abbott Laboratories",
    "510(k) Number": "K170320",
    "Predicate Device Reference 510(k) Number(s)": [
        "K980367"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "CGZ",
        "CEM",
        "JGS"
    ],
    "Summary Letter Date": "September 12, 2017",
    "Summary Letter Received Date": "September 13, 2017",
    "Submission Date": "January 31, 2017",
    "Regulation Number(s)": [
        "21 CFR 862.1170",
        "21 CFR 862.1600",
        "21 CFR 862.1665"
    ],
    "Regulation Name(s)": [
        "Chloride test system",
        "Electrode, ion-specific, potassium",
        "Electrode, ion-specific, sodium"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Sodium",
        "Potassium",
        "Chloride"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma",
        "Urine"
    ],
    "Specimen Container(s)": [
        "Serum tube",
        "Serum separator",
        "Lithium heparin tube",
        "Sodium heparin tube",
        "Plasma separator"
    ],
    "Instrument(s)/Platform(s)": [
        "Alinity c analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "Ion-selective electrode (ISE)",
        "Potentiometric"
    ],
    "Methodologies": [
        "Indirect ISE"
    ],
    "Submission Type(s)": [
        "Diluent",
        "Calibrator",
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for Alinity c ICT Sample Diluent used for quantitation of sodium, potassium, and chloride in serum, plasma, or urine on the Alinity c analyzer using indirect ion-selective electrode methodology.",
    "Indications for Use Summary": "For quantitation of sodium, potassium, and chloride in human serum, plasma, or urine to aid in diagnosis and treatment of electrolyte and metabolic disorders including aldosteronism, diabetes insipidus, adrenal hypertension, Addison's disease, dehydration, inappropriate antidiuretic hormone secretion, cystic fibrosis, and diabetic acidosis.",
    "fda_folder": "Clinical Chemistry"
}